Literature DB >> 21600541

Usefulness of peripheral vascular function to predict functional health status in patients with Fontan circulation.

Bryan H Goldstein1, Jessica R Golbus, Angela M Sandelin, Nicole Warnke, Lindsay Gooding, Karen K King, Janet E Donohue, James G Gurney, Caren S Goldberg, Albert P Rocchini, John R Charpie.   

Abstract

After the Fontan operation, patients are at a substantial risk of the development of impaired functional health status. Few early markers of suboptimal outcomes have been identified. We sought to assess the association between peripheral vascular function and functional health status in Fontan-palliated patients. Asymptomatic Fontan patients (n = 51) and age- and gender-matched healthy controls (n = 22) underwent endothelial pulse amplitude testing using a noninvasive fingertip peripheral arterial tonometry (PAT) device. Raw data were transformed into the PAT ratio, an established marker of vascular function. Cardiopulmonary exercise testing was performed using the Bruce protocol. In the Fontan cohort, 94% of patients were New York Heart Association functional class I and 88% had a B-type natriuretic peptide level of <50 pg/ml. The baseline pulse amplitude, a measure that reflects the arterial tone at rest, was greater in the Fontan patients than in the controls (median 2.74, interquartile range 1.96 to 4.13 vs median 1.86, interquartile range 1.14 to 2.79, p = 0.03). The PAT ratio, a measure of reactive hyperemia, was lower in Fontan patients (median 0.17, interquartile range -0.04 to 0.44, vs median 0.50, interquartile range 0.27 to 0.74, p = 0.002). The key parameters of exercise performance, including peak oxygen consumption (median 28.8 ml/kg/min, interquartile range 25.6 to 33.2 vs median 45.5 ml/kg/min, interquartile range 41.7 to 49.9, p <0.0001) and peak work (median 192 W, interquartile range 150 to 246 vs median 330, interquartile range 209 to 402 W, p <0.0001), were lower in Fontan patients than in the controls. The PAT ratio correlated with the peak oxygen consumption (r = 0.28, p = 0.02) and peak work (r = 0.26, p = 0.03). In conclusion, in an asymptomatic Fontan population, there is evidence of reduced basal peripheral arterial tone and vasodilator response, suggesting dysfunction of the endothelium-derived nitric oxide pathway. Vasodilator function appears to correlate with exercise performance.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21600541     DOI: 10.1016/j.amjcard.2011.03.064

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

1.  Elevated Aortic Augmentation Index in Children Following Fontan Palliation: Evidence of Stiffer Arteries?

Authors:  Deepti P Bhat; Pooja Gupta; Sanjeev Aggarwal
Journal:  Pediatr Cardiol       Date:  2015-04-02       Impact factor: 1.655

2.  Peripheral Endothelial Function After Arterial Switch Operation for D-looped Transposition of the Great Arteries.

Authors:  Heather Y Sun; Katie Jo Stauffer; Susan E Nourse; Chau Vu; Elif Seda Selamet Tierney
Journal:  Pediatr Cardiol       Date:  2017-03-27       Impact factor: 1.655

3.  High Overweight and Obesity in Fontan Patients: A 20-Year History.

Authors:  Stephanie T Chung; Borah Hong; Lance Patterson; Christopher J Petit; J Nina Ham
Journal:  Pediatr Cardiol       Date:  2015-09-16       Impact factor: 1.655

4.  Effect of Inhaled Nitric Oxide on Blood Flow Dynamics in Patients After the Fontan Procedure Using Cardiovascular Magnetic Resonance Flow Measurements.

Authors:  Heiner Latus; Bettina Gerstner; Gunter Kerst; Axel Moysich; Kerstin Gummel; Christian Apitz; Juergen Bauer; Dietmar Schranz
Journal:  Pediatr Cardiol       Date:  2015-11-07       Impact factor: 1.655

5.  Results of a phase I/II multi-center investigation of udenafil in adolescents after fontan palliation.

Authors:  David J Goldberg; Victor Zak; Bryan H Goldstein; Shan Chen; Michelle S Hamstra; Elizabeth A Radojewski; Eileen Maunsell; Seema Mital; Shaji C Menon; Kurt R Schumacher; R Mark Payne; Mario Stylianou; Jonathan R Kaltman; Tina M deVries; James L Yeager; Stephen M Paridon
Journal:  Am Heart J       Date:  2017-03-06       Impact factor: 4.749

6.  Higher dose of resveratrol elevated cardiovascular disease risk biomarker levels in overweight older adults - A pilot study.

Authors:  R T Mankowski; L You; T W Buford; C Leeuwenburgh; T M Manini; S Schneider; P Qiu; S D Anton
Journal:  Exp Gerontol       Date:  2019-12-28       Impact factor: 4.032

7.  Hemodynamic and Clinical Implications of Impaired Pulmonary Vascular Reserve in the Fontan Circulation.

Authors:  Alexander C Egbe; William R Miranda; Jason H Anderson; Barry A Borlaug
Journal:  J Am Coll Cardiol       Date:  2020-12-08       Impact factor: 27.203

Review 8.  Functional Capacity in Congenital Heart Disease: A Systematic Review and Meta-Analysis.

Authors:  Camila Wohlgemuth Schaan; Aline Chagastelles Pinto de Macedo; Graciele Sbruzzi; Daniel Umpierre; Beatriz D Schaan; Lucia Campos Pellanda
Journal:  Arq Bras Cardiol       Date:  2017-09-04       Impact factor: 2.000

9.  Endothelial Function and Arterial Stiffness Relate to Functional Outcomes in Adolescent and Young Adult Fontan Survivors.

Authors:  Bryan H Goldstein; Elaine M Urbina; Philip R Khoury; Zhiqian Gao; Michelle A Amos; Wayne A Mays; Andrew N Redington; Bradley S Marino
Journal:  J Am Heart Assoc       Date:  2016-09-24       Impact factor: 5.501

10.  Health-Related Quality of Life in Children, Adolescents, and Adults With a Fontan Circulation: A Meta-Analysis.

Authors:  Kate H Marshall; Yves D'Udekem; Gary F Sholler; Alexander R Opotowsky; Daniel S J Costa; Louise Sharpe; David S Celermajer; David S Winlaw; Jane W Newburger; Nadine A Kasparian
Journal:  J Am Heart Assoc       Date:  2020-03-16       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.